Alicia Vazquez, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vazquez’s office at (408) 937-1894 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$599 in 2024
Medicaid paid $599 for 822 billed services this clinician did in 2024, up to 51 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| LIMITED VISUAL FIELD XM UNI/BI I&R | 223 | $363 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $149 |
| Screening performed and negative | 260 | $87 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 217 | $0 |
| Short return visit (20+ min) | 108 | $0 |
| 2024 | 822 | 5 | 51 | $599 |
| 2023 | 1,775 | 14 | 60 | $29,844 |
| 2022 | 2,036 | 13 | 73 | $31,612 |
| 2021 | 1,956 | 12 | 78 | $31,746 |
| 2020 | 2,840 | 16 | 75 | $37,455 |
| 2019 | 2,463 | 18 | 73 | $30,594 |
| 2018 | 2,839 | 16 | 110 | $40,768 |
See the largest Medicaid services in earlier years
2023
| LIMITED VISUAL FIELD XM UNI/BI I&R | 368 | $12,316 |
| Pure tone audiometry (threshold); air only | 335 | $5,629 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 111 | $5,501 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 77 | $3,045 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 141 | $1,232 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 28 | $948 |
| Developmental screening | 12 | $660 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use | 16 | $149 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 14 | $119 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 13 | $109 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 13 | $109 |
| Short return visit (20+ min) | 235 | $26 |
2022
| LIMITED VISUAL FIELD XM UNI/BI I&R | 397 | $12,352 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 129 | $6,408 |
| Pure tone audiometry (threshold); air only | 384 | $5,998 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 97 | $3,094 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 278 | $2,136 |
| Developmental screening | 13 | $726 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 13 | $371 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 38 | $288 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 16 | $109 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 12 | $99 |
| Screening performed and negative | 329 | $30 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 42 | $0 |
2021
| LIMITED VISUAL FIELD XM UNI/BI I&R | 379 | $12,425 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 129 | $6,529 |
| Pure tone audiometry (threshold); air only | 372 | $6,152 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 96 | $3,384 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 206 | $1,557 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 25 | $742 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 32 | $298 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 25 | $228 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 24 | $208 |
| Short return visit (20+ min) | 411 | $132 |
| Screening performed and negative | 244 | $91 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 13 | $0 |
2020
| LIMITED VISUAL FIELD XM UNI/BI I&R | 367 | $12,534 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 135 | $7,160 |
| Pure tone audiometry (threshold); air only | 372 | $6,255 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 145 | $5,147 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 284 | $2,417 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 45 | $1,189 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 259 | $556 |
| Screening performed and negative | 475 | $542 |
| Skin test; tuberculosis, intradermal | 166 | $476 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 46 | $337 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 48 | $327 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 30 | $218 |
2019
| LIMITED VISUAL FIELD XM UNI/BI I&R | 324 | $10,972 |
| Pure tone audiometry (threshold); air only | 329 | $5,450 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 108 | $5,017 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 141 | $4,979 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 192 | $1,524 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 381 | $818 |
| Skin test; tuberculosis, intradermal | 182 | $522 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 44 | $377 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 15 | $247 |
| Short return visit (20+ min) | 569 | $140 |
| HEMOGLOBIN | 87 | $132 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 13 | $109 |
2018
| LIMITED VISUAL FIELD XM UNI/BI I&R | 402 | $13,660 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 199 | $8,701 |
| Pure tone audiometry (threshold); air only | 396 | $6,715 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 98 | $5,138 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 81 | $2,885 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 195 | $1,399 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 449 | $1,008 |
| Skin test; tuberculosis, intradermal | 164 | $537 |
| HEMOGLOBIN | 144 | $299 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 14 | $119 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 13 | $109 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 12 | $109 |
Money from drug and device companies
$154 in 2025
| 2025 | 1 | 3 | None | $154 |
| 2024 | 1 | 1 | None | $21 |
| 2023 | 1 | 1 | None | $115 |
| 2022 | 1 | 1 | None | $82 |
| 2021 | 1 | 1 | None | $18 |
| 2020 | 1 | 1 | None | $33 |
| 2019 | 1 | 2 | None | $138 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Penmenvy | $154 | 3 payments
|
See all 3 published payments
| GlaxoSmithKline | Meals · 2025-09-16 | Penmenvy | $122 |
| GlaxoSmithKline | Meals · 2025-06-04 | Bexsero | $20 |
| GlaxoSmithKline | Meals · 2025-01-28 | Bexsero | $12 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $21
| Pfizer | Prevnar 20 | $21 | 1 payment
|
2023: $115
| GlaxoSmithKline | None | $115 | 1 payment
|
2022: $82
| GlaxoSmithKline | Bexsero | $82 | 1 payment
|
2021: $18
| Merck Sharp & Dohme | Gardasil 9 | $18 | 1 payment
|
2020: $33
| GlaxoSmithKline | Bexsero | $33 | 1 payment
|
2019: $138
| GlaxoSmithKline | Bexsero | $138 | 2 payments
|
Professional record
- NPI
- 1215974241
- Licence
- CA AO54367
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2820 Alum Rock Ave, Suite 50, San Jose, CA, 95127
- NPI first listed
- 2006-05-31
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.